Funding for this research was provided by:
Beijing Municipal Science & Technology Commission (Z181100001918002, Z181100006218032)
CAMS Initiative for Innovative Medicine (2017-I2M-1-005)
The National Key R&D Program of China (2018YFC1312103, 2017YFC1311003, 2017YFC1308702)
Text and Data Mining valid from 2019-10-02
Received: 4 June 2019
Accepted: 20 September 2019
First Online: 2 October 2019
Ethics approval and consent to participate
: This study was approved by the Institute Research Medical Ethics Committee of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital in Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing. Paired tumor and normal tissue specimens were obtained from the biobank of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital in Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing. All tissue samples were collected in compliance with an informed consent policy. Written informed consent was obtained from all the patients at the time of admission for the use of their tissue, blood or other samples for scientific research, and patient privacy was protected.
: The study participants provided written consent for the publication of their clinical data.
: The authors declare that they have no competing interests.